Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
48%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
PPH
26
HOLDINGS
52%
ALSO IN IHE
IHE
36
HOLDINGS
34%
ALSO IN PPH
SECTOR DRIFT (PPH minus IHE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PPH |
Weight in IHE |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 17.1% | 19.1% | 17.1% | |
JOHNSON & JOHNSON | 11.6% | 24.4% | 11.6% | |
MERCK & CO. INC. | 6.2% | 4.5% | 4.5% | |
PFIZER INC | 4.7% | 4.3% | 4.3% | |
BRISTOL-MYERS SQUIBB CO | 4.3% | 4.0% | 4.0% |
PPH Overweight Relative to IHE
NOVARTIS AG-ADR | 8.1% | |
NOVO-NORDISK A/S-SPONS ADR | 6.0% | |
ABBVIE INC | 5.1% | |
ASTRAZENECA PLC-SPONS ADR | 5.1% | |
GLAXOSMITHKLINE PLC-SPON ADR | 4.5% | |
MCKESSON CORP | 4.4% | |
SANOFI-AVENTIS-ADR | 4.3% | |
CENCORA INC | 3.7% | |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 2.9% | |
TEVA PHARMACEUTICAL-SP ADR | 1.8% |
PPH Underweight Relative to IHE
JOHNSON & JOHNSON | -12.8% | |
ROYALTY PHARMA PLC CLASS A | -4.5% | |
VIATRIS, INC. | -4.2% | |
ELANCO ANIMAL HEALTH, INC. | -3.8% | |
JAZZ PHARMACEUTICALS PLC | -3.1% | |
CORCEPT THERAPEUTICS INC | -3.0% | |
AXSOME THERAPEUTICS, INC. | -2.1% | |
ELI LILLY & CO | -2.0% | |
LIGAND PHARMACEUTICALS-CL B | -1.5% | |
PRESTIGE BRANDS HOLDINGS INC | -1.5% |